Taxifolin Supplements Demonstrate Protective Effects Against Lupus and Antiphospholipid Syndrome
A new first-of-its-kind study found taxifolin supplements have protective effects on thrombo-inflammatory diseases, such as lupus and antiphospholipid syndrome(APS). Taxifolin, which is also known as dihydroquercetin, is a bioactive plant-derived flavonoid that has a wide range of health-supporting, anti-inflammatory and anti-oxidative properties.
Read full article on The Lupus Foundation of America.
Featured News & Stories
Department News
NIH National Center for Biomedical Imaging and Bioengineering (NCBIB) Workshop
NIH National Center for Biomedical Imaging and Bioengineering (NCBIB) Workshop
Department News
Professor Diane Harper selected as the Michigan Family Physician of the Year for 2026
Professor Diane M. Harper, MD, MPH, MS, has received several honors, including Physician of the Year for 2026 by the Michigan Academy of Family Physicians, and has been honored as Kansas University School of Medicine with its Distinguished Alumni Award.
Health Lab
Using genetic testing, doctors help patient find answers for her diabetes
For 30 years Autumn Caris thought she had type 1 diabetes. After learning about MODY, a rare and often misdiagnosed type of diabetes, she finally got answers at U-M.
Michigan Medicine Presents
Michigan Medicine Presents: Tommy Wang, M.D., Dean, University of Michigan Medical School
Join MD student Cassie Evans and PhD student Sam Collie for a wide-ranging conversation with Dean Tommy Wang, M.D. As he reflects on his journey to medicine and academic leadership, Dr. Wang shares his perspectives on student well-being, artificial intelligence, education, research and patient care through the lens of his new role as dean of the University of Michigan Medical School.
Department News
Michigan Urology Residency Program Ranked #2 Nationally
Michigan Urology’s residency program earned the #2 Doximity national ranking, reflecting excellence in training, research, and patient care.
Department News
New initiative aims to bridge gap between emergency room and long-term treatment for opioid addiction
A new University of Michigan-led program aims to help rural communities improve access to evidence-based treatment for opioid use disorder and create smoother transitions from emergency care to long-term support. The Michigan Department of Health and Human Services Rural Health Transformation Program has awarded U-M's OPEN a $1.5 million, 14-month grant to launch the Rural Medications for Opioid Use Disorder Link Initiative.
